EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study

Riccardo Candido, Antonio Nicolucci, Monica Larosa, Maria Chiara Rossi, Raffaele Napoli, RESTORE-G (Retrospective analysis on the therapeutic approaches after GLP-1 RA treatment in type 2 diabetes patients) Study Group

Nutrition, Metabolism and Cardiovascular Diseases · 2023

DOI: 10.1016/j.numecd.2023.07.025 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2023. Verfasst von Riccardo Candido und 5 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Centre District 4, Azienda Sanitaria Universitaria Integrata, Trieste, Italy. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor Agonists, Hypoglycemic Agents, Incretins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sanofi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Glucagon-Like Peptide-1 Receptor AgonistsHypoglycemic AgentsIncretinsInsulinBlood GlucoseGlycemic ControlHumansFemaleMaleMiddle AgedAgedTreatment OutcomeItalyTime FactorsBiomarkersGlycated HemoglobinElectronic Health RecordsRetrospective StudiesDrug SubstitutionDrug Therapy, CombinationDrug Administration ScheduleGlucagon-Like Peptide-1 Receptor

Stichwörter der Autor:innen

Basal insulinEffectivenessFixed-ratio combinationGLP-1 receptor agonistsInsulin naïveSafetyType 2 diabetes

Substanzen

Glucagon-Like Peptide-1 Receptor AgonistsHypoglycemic AgentsIncretinsInsulinBlood GlucoseBiomarkershemoglobin A1c protein, humanGlycated HemoglobinGLP1R protein, humanGlucagon-Like Peptide-1 Receptor

Autor:innen und Institutionen

  • Diabetes Centre District 4, Azienda Sanitaria Universitaria Integrata, Trieste, Italy.
  • CORESEARCH, Center for Outcomes Research and Clinical Epidemiology, Pescara, Italy. Electronic address: nicolucci@coresearch.it.
  • Medical Affairs, Sanofi S.r.l., Milan, Italy.
  • CORESEARCH, Center for Outcomes Research and Clinical Epidemiology, Pescara, Italy.
  • Department of Translational Medical Sciences, Unit of Internal Medicine and Diabetes, Federico II University School of Medicine and Institute of Experimental Endocrinology and Oncology, National Research Council, Napoli…

Förderung

  • Sanofi

Zitieren

APA

Candido, R., Nicolucci, A., Larosa, M., Rossi, M. C., Napoli, R., & RESTORE-G (Retrospective analysis on the therapeutic approaches after GLP-1 RA treatment in type 2 diabetes patients) Study Group (2023). Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2023.07.025

Vancouver

Candido R, Nicolucci A, Larosa M, Rossi MC, Napoli R, RESTORE-G (Retrospective analysis on the therapeutic approaches after GLP-1 RA treatment in type 2 diabetes patients) Study Group. Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study. Nutrition, Metabolism and Cardiovascular Diseases. 2023. doi:10.1016/j.numecd.2023.07.025

BibTeX
@article{Candido2023,
  author = {Candido, Riccardo and Nicolucci, Antonio and Larosa, Monica and Rossi, Maria Chiara and Napoli, Raffaele and RESTORE-G (Retrospective analysis on the therapeutic approaches after GLP-1 RA treatment in type 2 diabetes patients) Study Group, RESTORE-G (Retrospective analysis on the therapeutic approaches after GLP-1 RA treatment in type 2 diabetes patients) Study Group},
  title = {Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2023},
  doi = {10.1016/j.numecd.2023.07.025}
}
Kostenlos starten →